Prokineticin 2 is an endangering mediator of cerebral ischemic injury

Stroke causes brain dysfunction and neuron death, and the lack of effective therapies heightens the need for new therapeutic targets. Here we identify prokineticin 2 (PK2) as a mediator for cerebral ischemic injury. PK2 is a bioactive peptide initially discovered as a regulator of gastrointestinal m...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cheng, Michelle Y., Lee, Alex G., Culbertson, Collin, Sun, Guohua, Talati, Rushi K., Manley, Nathan C., Li, Xiaohan, Zhao, Heng, Lyons, David M., Zhou, Qun-Yong, Steinberg, Gary K., Sapolsky, Robert M.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2012
Teme:
Biological Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325724/
https://ncbi.nlm.nih.gov/pubmed/22431614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1113363109
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items